Increased India Drug Exports To U.S. Draw Stepped-Up Plant Inspections
This article was originally published in PharmAsia News
Executive Summary
India drug exports to the U.S. may be increasing sales and profits, but they also have elicited greater attention to their safety, leading in some cases to rejection of products from certain plants.